Potential application of neonatal porcine islets as treatment for type 1 diabetes: A review

Annals of the New York Academy of Sciences

Volumn 875, Issue , 1999, Pages 175-188

  Rayat, Gina R ^a   Rajotte, Ray V ^a   Korbutt, Gregory S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCOMPATIBILITY; CELL AGGREGATION; CELL COMPOSITION; CELL ISOLATION; CELL STRUCTURE; CELL TRANSPLANTATION; CONFERENCE PAPER; EPITHELIUM CELL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; SWINE; XENOTRANSPLANTATION;

ANIMALIA; MUS MUSCULUS; SUIDAE; SUS SCROFA;

EID: 0032803512     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08502.x     Document Type: Conference Paper

References (117)

1. 1. BLISS, M. 1982. The discovery of insulin. McLelland & Stewart Inc. Toronto, p. 11.
2. 2. LACY, P.E. 1995. Islet cell transplantation for insulin-dependent diabetes. Hospital Practice 30: 41-45.
3. 3. BRANDHORST, D., H. BRANDHORST, B.J. HERING, K. FEDERLIN & R.G BRETZEL. 1995. Islet isolation from the pancreas of large mammals and humans: 10 years of experience. Exp. Clin. Endocrinol. 103: 3-14.
4. 4. BRANDHORST, H., D. BRANDHORST, B.J. HERING, K. FEDERLIN & R.G. BRETZEL. 1995. Body mass index of pancreatic donors: a decisive factor for human islet isolation. Exp. Clin. Endocrinol. 103: 23-26.
5. 5. BRETZEL, R.G., B.J. HERING & K.F. FEDERLIN. 1995. Islet cell transplantation in diabetes mellitus - from bench to bedside. Exp. Clin. Endocrinol. 103: 143-159.
6. 6. CALAFIORE, R. 1997. Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM. Diabetes Care 20: 889-896.
7. 7. SLOVER, R.H. & G.S EISENBARTH. 1997. Prevention of type I diabetes and recurrence of β-cell destruction of transplanted islets. Endocrine Rev. 18: 241-258.
8. 8. SCHARP, D.W., P.E. LACY, J.V. SANTIAGO, C.S. McCULLOUGH, L.G. WEIDE, L. FALQUI, P. MARCHETTI, R.L. GINGERICH, A.S. JAFFE, P.E. CRYER, C.B. ANDERSON & M.W. FLYE. 1990. Insulin independence after islet transplantation into type 1 diabetic patient. Diabetes 39: 515-518.
9. 9. WARNOCK, G.L., N.M. KNETEMAN, E. RYAN, R.E. SEELIS, A. RABINOVITCH & R.V. RAJOTTE. 1991. Normoglycemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 55-58.
10. 10. SOCCI, C., L. FALQUI, A.M. DAVALLI, C. RICORDI, S. BRAGHI, F. BERTUZZI, P. MAFFI, A. SECCI, F. GAVAZZI, M. FRESCHI, P. MAGISTRETTI, S. SOCCI, A. VIGNALI, V. DI CARLO & G. POZZA. 1991. Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients: report of six cases. Acta Diabetol. 128: 151-157.
11. 11. WARNOCK, G.L., N.M. KNETEMAN, E.A. RYAN, A. RABINOVITCH & R.V. RAJOTTE. 1992. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 89-95.
12. 12. RICORDI, C., A.G. TZAKIS, P.B. CARROLL, Y.J. ZENG, H.L. RILO, R. ALEJANDRO, A. SHAPIRO, J.J. FUNG, A.J. DEMETRIS, D.H. MINTZ & T.E. STARZL. 1992. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 53: 407-414.
13. 13. GORES, P.F., J.S. NAJARIAN, E. STEPHANIAN, J.J. LLOVERAS, S.L. KELLEY & D.E. SUTHERLAND. 1993. Insulin independence in type 1 diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 341: 19-21.
14. 14. ALEJANDRO R., R. LEHMANN, C. RICORDI, N.S. KENYON, M.C. ANGELICO, G. BURKE, V. ESQUENAZI, J. NERY, A.E. BETANCOURT, S.S. KONG, J. MILLER & D.H. MINTZ. 1997. Long-term function (6 years) of islet allografts in type I diabetes. Diabetes 46: 1983-1989.
15. 15. RICORDI, C., C. SOCCI, C. DAVALLI, C. STAUDACHER, P. BARO, A. VERTOVA, I. SASSI, F. GAVAZZI, G. POZZA & V. DICARLO. 1989. Isolation of the elusive pig islet. Surgery 107: 688-694.
16. 16. KORSGREN, O., L. JANSSON, D. EIZIRIK & A. ANDERSSON. 1991. Functional and morphological differentiation of fetal porcine islet-like clusters after transplantation into nude mice. Diabetologia 34: 379-386.
17. 17. LUI X., K.F. FEDERLIN, R.G. BRETZEL, B.J. HERING & M.D. BRENDAI. 1991. Persistent reversal of diabetes by transplantation of fetal pig proislets into nude mice. Diabetes 40: 858-866.
18. 18. GROTH, C.G., O KORSGREN, A. TIBELL, J. TOLLFMAR, E. MOLLER, J. BOLINDER, J. OSTMAN, F.R. REINHOLD, C. HELLERSTROM & A. ANDERSSON. 1994. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344: 1402-1404.
19. 19. DAVALLI, A.M., Y. OGAWA, L. SCALIA, Y-J. WU, J. HOLLISTER, S. BONNER-WEIR & G.C. WEIR. 1995. Function, mass and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44: 104-111.
20. 20. MARCHETTI, P., R. GIANNARELLI, S. COSMI, P. MASIELLO, A. COPPELLI, P. VIACAVA & R. NAVALESI. 1995. Massive isolation, morphological and functional characterization, and xenotransplantalion of bovine pancreatic islets. Diabetes 44: 375-381.
21. 21. WRIGHT, J.R., S. POLVI & S. MACLEAN, 1992. Experimental transplantation with principal islets of telcost fish (Brockman bodies). Long-term function of tilapia islet tissue in diabetic nude mice. Diabetes 41: 1528-1532.
22. 22. FERBER S., H. BELTRANDELRIO, J.H. JOHNSON, R.J. NOEL, L.E. CASSIDY, S. CLARK, T.C. BECKER, S.D. HUGHES & C.B. NEWGARD. 1994. GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. J. Biol. Chem. 269: 11523-11529.
23. 23. KNAACK, D., D.M. FIORE, M. SURANA, M. LEISER, M. LAURANCE, D. FUSCO-DEMANE, O. D. HEGRE, N. FLEISCER & S. EFRAT. 1994. Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 43: 1413-1417.
24. 24. EFRAT, S., D. FUSCO-DEMANE, H. LEMBERG, O. EMRAN & X. WANG. 1995. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. USA 92: 3576-3580.
25. 25. KOVER K. & W. V. MOORE. 1989. Development of a method for isolation of islets from human fetal pancreas. Diabetes 38: 917-924.
26. 26. HAYEK, A., G. M. BEATTIE, V. CIRULLI, A. D. LOPEZ, C. RICORDI & J.S. RUBIN. 1995. Growth factor/matrix-induced proliferation of human adult β-cells. Diabetes 44: 1458-1460.
27. 27. SMITH, R. M. & T. E. MANDEL. 1998. Transplantation treatment for diabetes. Immunol. Today 19: 444-447.
28. 28. KORBUTT, G.S., J.F. ELLIOTT, Z. AO, D.K. SMITH, G.L. WARNOCK & R.V. RAJOTTE. 1996. Large scale isolation, growth, and function of porcine neonatal islet cells. J. Clin. Invest. 97: 2119-2129.
29. 29. WEBER, C.J., M.K. HAGLER, J.T. CHRYSSOCHOOS, J.A. KAPP, G.S. KORBUTT, R.V. RAJOTTE & P.S. LINSLEY. 1997. CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice. Cell Transplant. 6: 505-508.
30. 30. SCHILLING, A., W. LAND, E. PRATSCHKE, K. PIELSTICKER & W. BRENDEL. 1976. Dominant role of complement in the hyperacute xenograft rejection reaction. Surgery, Gynecol. & Obst. 142: 29-32.
31. 31. AUCHINCLOSS, H., JR. 1988. Xenogeneic transplantation. A review. Transplantation 46: 1-20.
32. 32. PLATT, J.L., G.M. VERCELLOTTI, A.P. DALMASSO, A.J. MATAS, R.M. BOLMAN, J.S. NAJARIAN & F.H. BACH. 1990. Transplantation of discordant xenografts: A review of progress. Immunol. Today 11: 450-456
33. 33. PLATT, J.L. & F.H. BACH. 1991. The barrier to xenotransplantation. Transplantation 52: 937-947.
34. 34. BALDWIN, W.M. III, S.K. PRUITT, R.B. BRAUER, M.R. DAHA & F. SANFILIPPO. 1995. Complement in organ transplantation - contributions to inflammation, injury and rejection. Transplantation 59: 797-808.
35. 35. GALILI, U., E.A. RACHMILEWITZ, A. PELEG & I. FLECHNER. 1984. A unique natural human IgG antibody with anti-galactosyl specificity. J. Exp. Med. 160: 1519-1531.
36. 36. GALILI, U. 1993. Interaction of natural anti-Gal antibody with galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol. Today 14: 480-482.
37. 37. SANDRIN, M.S., H.A. VAUGHAN, P.L. DABKOWSKI & I.F.C. McKENZIE. 1993. Anti-pig IgM antibodies in human serum react predominantly with Galα(1,3)Gal epitopes. Proc. Natl. Acad. Sci. USA 90: 11391-11395.
38. 38. McMORROW, I., C. COMRACK, D. SACHS & H. DERSIMONIAN. 1997. Transplantation 64: 501-510.
39. 39. ORIOL, R., Y. YE, E. KOREN & D.K.C. COOPER. 1993. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 56: 1433-1442.
40. 40. McKENZIE, I.F.C., P.X. XING, H.A. VAUGHAN, J. PRENZOSKA, P.L. DABKOWSKI & M.S. SANDRIN. 1994. Distribution of the major xenoantigen (galα(1-3)gal) for pig to human xenografts. Transplant. Immunol. 2: 81-86.
41. 41. RYDBERG, L., C.G. GROTH, E. MOLLER, A. TIBELL & B.E. SAMUELSSON: 1995. Is the Galα(1,3)Gal epitopes a major target for xenoantibodies on pig fetal islet cells? Xenotransplantation 2: 148-153.
42. 42. McKENZIE, I.F.C., M. KOULMANDA, T.E. MANDEL, P.X. XING & M.S. SANDRIN. 1995. Pig-to-human xenotransplantation. The expression of Galα(1,3)Gal epitopes on pig islet cells. Xenotransplantation 2: 1-7.
43. 43. SATAKE, M., M. KUMAGAI-BRAESCH, O. KORSGREN, A. ANDERSSON & E. MOLLER. 1993. Characterization of humoral human anti-porcine xenoreactivity. Clin. Transplant. 7: 281-288.
44. 44. KORBUTT, G.S., L. ASPESLET, R.V. RAJOTTE, G.L WARNOCK, Z. AO, J. EZEKOWITZ, A.J. MALCOLM, A. KOSHAL & R.W. YATSCOFF. 1996. Natural human antibody-mediated destruction of porcine neonatal islet cell grafts. Xenotransplanlation 3: 207-216.
45. 45. SCHAAPHERDER, A.F.M., M.R. DAHA, F.J. VAN DER WOUDE, J.A. BRUIJN & H.G. GOOSZEN. 1993. IgM, IgG, and IgA antibodies in human sera directed against porcine islets of Langerhans. Transplantation 58: 1576-1578.
46. 46. SCHAAPHERDER, A.F.M., M.C.J. WOLVEKAMP, M.T.J.W. TE BULTE, E. BOUWMAN, H.G. GOOSZEN & M.R. DAHA. 1996. Porcine islets of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms. Transplantation 62: 29-33.
47. 47. RAYAT, G.R., R.V. RAJOTTE, J.F. ELLIOTT & G.S. KORBUTT. 1998. Expression of Galα(1,3)Gal on neonatal porcine islet β-cells and susceptibility to human antibody/complement lysis. Diabetes 47: 1406-1411.
48. 48. McKENZIE, I.F., M. KOULMANDA, T.E. MANDEL & M.S. SANDRIN. 1998. Pig islet xenografts are susceptible to anti-pig but not to Galα(1,3)Gal antibody plus complement in Gal o/o mice. J. Immunol. 161: 5116-5119.
49. 49. AZIMZADEH, A., I. ANEGON, K. THIBAUDEAU, B. CHARREAU, P. ZIBOLT, J. CINQUALBRE & J.P. SOULILLOU. 1997. Removal of anti-Galα(1,3)Gal antibodies diminishes the cytotoxic effect of primate xenoreactive antibodies on rat endothelial cells. Transplant. Proc. 29: 2337.
50. 50. WEISS, R. A. Transgenic pigs and virus adaptation. 1998. Nature 39: 327-328.
51. 51. PRUITT, S.K., W.M. BALDWIN III, H.C. MARSH JR., S.S. LIN, C.G. YEH & R.R. BOLLINGER. 1991. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52: 868-873.
52. 52. XIA, W., D.T. FEARON & R.L. KIRKMAN. 1993. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. Transplant. Proc. 25:410-411.
53. 53. PRUITT, S.K., A.D. KIRK, R.R. BOLLINGER, H.C. MARSH JR., B.H. COLLINS, J.L. LEVIN, J.R. MAULT, J.S. HEINLE, S. IBRAHIM, A.R. RUDOLPH, W.M. BALDWIN III & F. SANFILIPPO. 1994. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57: 363-370.
54. 54. CANDINAS, D., B.-A. LESNIKOSKI, S.C. ROBSON, T. MIYATAKE, S.M. SCESNEY, H.C. MARSH JR., U.S. RYAN, A.P. DALMASSO, W.W. HANCOCK & F.H. BACH. 1996. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 62: 336-342.
55. 55. CHEN, C.-G., N. FISICARO, T.A. SHINKEL, V. AITKEN, M. KETERELOS, B.J.W. VAN DENDEREN, M.J. TANGE, R.J. CRAWFORD, A.J. ROBINS, M.J. PEARSE & A.J.F. D'APICE. 1996. Reduction in Gal-α1,3-Gal epitope expression in transgenic mice expressing human H-transferase. Xenotransplantation 3: 69-75.
56. 56. SANDRIN, M.S., W.L. FODOR, S. COHNEY, E. MOUHTOURIS, N. OSMAN, S.A. ROLLINS, S.P. SQUINTO & I.F.C. McKENZIE. 1996. Reduction of the major porcine xenoantigen Gal(1,3)Gal by expression of α(1,2)fucosyltransferase. Xenotransplantation 3: 134-140.
57. 57. KOIKE, C., R. KANNAGI, Y. TAKUMA, F. AKUTSU, S. HAYASHI, N. HIRAIWA, K. KAOMATSU, T. MURAMATSU, H. YAMAKAWA, T. NAGAI, S. KOBAYASHI, H. OKADA, I. NAKASHIMA, K. UCHIDA, I. YOKOYAMA & H. TAKAGI. 1996. Introduction of α(1,2)-fucosyltransferase and its effect on α-Gal epitopes in transgenic pig. Xenotransplantation 3: 81-86.
58. 58. TEARLE, R.G., M.J. TANGE, Z.L. ZANNETTINO, M. KATERELOS, T.A. SHINKEL, B.J.W. VAN DENDEREN, A.J. LONIE, I. LYONS, M.B. NOTTLE, T. COX, C. BECKER, A.M. PEURA, P.L. WIGLEY, R.J. CRAWFORD, A.J. ROBINS, M.J. PEARSE & A.J.F. D'APICE. 1996. The α-1,3-Galactosyltransferase knockout mouse. Transplantation 61: 13-19.
59. 59. TANGE, M.J., E. SALVARIS, M. ROMANELLA, A. AMINIAN, M. KATERELOS, C. SOMERVILLE, R.G. TEARLE, M.J. PEARSE & A.J.F. D'APICE. 1997. Additive effects of CD59 expression in Gal knockout mice in vitro but not in an ex vivo model. Xenotransplantation 4: 25-33.
60. 60. McCURRY, K.R., D.L. KOOYMAN, C.G. ALVARADO, A.H. COTTERELL, M.J. MARTIN, J.S. LOGAN & J.L. PLATT. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1: 423-427.
61. 61. COZZI, E. & D.J.G. WHITE. 1995. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1: 964-966.
62. 62. CARY, N., J. MOODY, N. YANNOUTSOS, J. WALLWORK & D. WHITE. 1993. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: A potential approach to inhibition of hyperacute xenograft rejection. Transplant. Proc. 25: 400-401.
63. 63. DIAMOND, L., E.R. OLDHAM, J. L. PLATT, H. WALDMANN, M. TONE, L.A. WALSH & J.S. LOGAN. 1994. Cell and tissue specific expression of a human CD59 minigene in transgenic mice. Transplant. Proc. 26: 1239.
64. 64. ROSENGARD, A.M., N.R. CARY, G.A. LANGFORD, A.W. TUCKER, J. WALLWORK & D.J. WHITE. 1995. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs - a potential approach for preventing xenograft rejection. Transplantation 59: 1325-1333.
65. 65. LANGFORD, G.A., N. YANNOUTSOS, E. COZZI, R. LANCASTER, K. ELSOME, P. CHEN, A. RICHARDS & D.J. WHITE. 1995. Production of pigs transgenic for human decay accelerating factor. Transplant. Proc. 26: 1400-1401.
66. 66. GILL, R. G., L. WOLF & M. COULOMBE. 1994. CD4+ T cells are both necessary and sufficient for islet xenograft rejection. Transplant. Proc. 26: 1203.
67. 67. WOLF, L. A., M. COULOMBE & R.G. GILL. 1995. Donor antigen-presenting cell-independent rejection of islet xenografts. Transplantation 60: 1164-1170.
68. 68. MARCHETTI, P., D.W. SCHARP, E.H. FINKE, C.J. SWANSON, B.J. OLEK, D. GERASIMIDIVAZEOU, R. GRANNARELLI, R. NAVALES & P.E. LACY. 1996. Prolonged survival of discordant porcine islet xenografts. Transplantation 61: 1100-1102.
69. 69. PIERSON, R. N. III, H.J. WINN, P.S. RUSSELL & H. AUCHINCLOSS JR. 1989. Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J. Exp. Med. 170:991-996.
70. 70. DESAI, N.M., H. BASSIRI, J.S. ODORICO, B.H. KOLLER, O. SMITHIES, A. NAJI, C.F. BARKER & J.F. MARKMANN. 1993. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients. Transplant. Proc. 25: 961.
71. 71. OSORIO, R.W., N.L. ASCHER & P.G STOCK. 1994. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Transplantation 57: 783-788.
72. 72. MURRAY, A.G., M.M. KHODADOUST, J.S. POBER & A.L. BOTHWELL. 1994. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1: 57-63.
73. 73. YAMADA, K., D.H. SACHS & H. DERSIMONIAN. 1995. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J. Immunol. 155: 5249-5256.
74. 74. LENSCHOW, D. J., Y. ZENG, J.R. THISTLETHWAITE, A. MONTAG, W. BRADY, M.G. GIBSON, P.S. LINSLEY & J.A. BLUESTONE. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257: 789-792.
75. 75. SELAWRY, H.P., K.B. WHITTINGTON & D. BELLGRAU. 1989. Abdominal intratesticular islet xenograft survival in rats. Diabetes 38: 220-223.
76. 76. BAKER, C.F. & R.E. BILLINGHAM. 1977. Immunologically privileged sites. Adv. Immunol 25: 1-54.
77. 77. BOBZIEN, B., Y. YASUNAMI, M. MAJERCIK, P.E. LACY & J.M. DAVIE. 1983. Intratesticular transplants of islet xenografts (rat to mouse). Diabetes 32: 213-216.
78. 78. SELAWRY, H. & K. WHITTINGTON. 1984. Extended survival of islets grafted into the intra-abdominally placed testis. Diabetes 33: 405-406.
79. 79. WHITMORE III, W.F., L. KARSH & R.F. GITTES. 1985. The role of germinal epithelium and spermatogenesis in the privileged survival of intratesticular grafts. J. Urol. 134: 782-786.
80. 80. BELLGRAU, D., D. GOLD, H. SELAWRY, J. MOORE, A. FRANZUSOFF & R.C. DUKE. 1995. A role of CD95 ligand in preventing graft rejection. Nature 377: 630-632.
81. 81. STREILEIN, J.W. 1995. Unraveling immune privilege. Science 270: 1158-1159.
82. 82. NAGATA, S. & P. GOLDSTEIN. 1995. The Fas death factor. Science 267: 1449-1456.
83. 83. ALDERSON, M.R., T.W. ROUGH, T. DAVIS-SMITH, S. BRADDY, B. FALK, K.A. SCHOOLEY, R.G. GOODWIN, C.A. SMITH, F. RAMSDELL. & D.H. LYNCH. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
84. 84. LYNCH, D.H., F. RAMSDELL & M.R. ALDERSON. 1995. Fas and Fas 1 in the homeostatic regulation of immune responses. Immunol, Today 16: 569-574.
85. 85. KORBUTT, G.S., J.F. ELLIOTT & R.V. RAJOTTE. 1997. Cotransplantation of allogeneic islets with testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46: 317-322.
86. 86. SKINNER, M.K. 1991. Cell-cell interactions in the testis. Endocrin. Rev. 12: 45-77.
87. 87. CLARK, A. M. & M.D. GRISWOLD. 1997. Expression of clusterin/sulfated glycoprotein-2 under conditions of heat stress in rat sertoli cells and a mouse sertoli cell line. J. Androl. 18: 257-263.
88. 88. MURPHY, B.F., I.D. WALKER, L. KIRSZBAUM & A.J.F. D'APICE. 1988. SP-40-40-a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J. Clin. Invest. 81; 1858-1864.
89. 89. MURPHY, B.F., J.R. SAUNDERS, M.K. O'BRYAN, L. KIRSZBAUM, I.D. WALKER & A.J.F. D'APICE. 1989. SP-40-40 is an inhibitor of C5b-6 initiated hemolysis. Int. J. Immunol. 1: 551-554.
90. 90. WILSON, M.R., P.J. ROETH & S.B. EASTERBROOK-SMITH. 1991. Clusterin enhances the formation of insoluble immune complexes. Biochem. Biophys. Res. Commun. 177: 985-990.
91. 91. ROBERTS, A.B. & M.B. SPORN. 1988. Transforming growth factor beta. Adv. Can. Res. 51: 107-145.
92. 92. KORSGREN, O., L. JANSSON, D. EIZIRIK & A. ANDERSSON. 1991. Functional and morphological differentiation of fetal porcine islet-like clusters after transplantation into nude mice. Diabetologia 34: 379-386.
93. 93. BONNER-WEIR, S. & F.E. SMITH. 1994. Islet cell growth and the growth factors involved. Trends Endocrin. Metab. 5: 60-64.
94. 94. OTONKOSKI, T., G.M. BEATTIE, M.I. MALLY, C. RICORDI & A. HAYEK. 1993. Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J. Clin. Invest. 92: 1459-1466.
95. 95. OTONKOSKI, T., J. USTINOV, M.A. HUOTARI, E. KALLIO & P. HAYRY. 1996. Nicotinamide and sodium butyrate potent synergistic effects on fetal porcine β cell differentiation. Diabetologia 39 (Suppl. 1): 232A.
96. 96. HAYEK, A., G.M. BEATTIE, V. CIRULLI, A.D. LOPEZ, C. RICORDI & J.S. RUBIN. 1995. Growth factor/matrix-induced proliferation of human adult b-cells. Diabetes 44: 1458-1460.
97. 97. OTONKOSKI, T., G.M. BEATTIE, J.S. RUBIN, A.D. LOPEZ, A. BAIRD & A. HAYEK. 1994. Hepatocyte growth factor/scatter factor has insulitropic activity in human fetal pancreatic cells. Diabetes 43: 947-953.
98. 98. BEATTIE, G.M., J.S. RUBIN, M.I. MALLY, T. OTONKOSKI & A. HAYEK. 1996. Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes 45: 1223-1228.
99. 99. KERR-CONTE, J., F. PATTOU, M. LECOMTE-HOUCKE, X.J. XIA, B. BOILLY, C. PROYE & J. LEFEBVRE. 1996. Duetal cyst formation in collagen-embedded adult human islet preparations. Diabetes 45: 1108-1114.
100. 100. MONTESANO, R., P. MOURN, M. AMHERDT & L. ORCI. 1983. Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids. J. Cell Biol. 97: 935-939.
101. 101. GOSPODAROWICZ, D., G. GREENBURG & C.R. BIRDWELL. 1978. Determination of cellular shape by the extracellular matrix and its correlation with the control of cellular growth. Cancer Res. 38: 4155-4171.
102. 102. HAY, E.D. 1993. Extracellular matrix alters epithelial differentiation. Curr. Opin. Cell Biol. 5: 1029-1035.
103. 103. EMERAN, J.T. & D.R. PITELKA. 1977. Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro 13: 316-328.
104. 104. BATES, R.C., L.F. LINCZ & G.F. BURNS. 1995. Involvement of integrins in cell survival. Cancer Metastasis Rev. 14: 191-203.
105. 105. FRISCH, S.M. & H. FRANCIS. 1994. Disruption of epithelial cell-matrix interaction induces apoptosis. J. Cell Biol. 124: 619-126.
106. 106. SCHWARTZ, S M. & M.R. BENNETT. 1995. Death by any other name. Ant. J. Pathol. 147: 229-234.
107. 107. KERR, J.F.R., A.H. WYLLIE & A.R. CURRIE. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257.
108. 108. BEN ZE'EV, A., S.R. FARMER & S. PENMAN. 1980. Protein synthesis requires cell-surface contact while nuclear events respond to cell shape in anchorage-dependent fibroblasts. Cell 21: 365-372.
109. 109. HENEINE, W., A. TIBELL, W.M. SWITZER, P. SANDSTROM, G. VASQUEZ ROSALES, A. MATHEWS, O. KORSGREN, L.E. CHAPMAN, T.M. FOLKS & C.G. GROTH. 1998. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 352: 695-699.
110. 110. EIBER, M.M., C.J. SHERR, R.E. BENVENSISTE & G.J. TODARO. 1975. Biologic and immunologic properties of porcine type C viruses. Virology 66: 616-619.
111. 111. UZUKA, I., N. SHIMIZU, K. SEKIGUCHI, H. HOSHINO, M. KODAMA & K. SHIMOTOHNO. 1986. Molecular cloning of unintegrated closed circular DNA of porcine retrovirus. FEBA 198: 339-343.
112. 112. PATIENCE, C., Y. TAKEUCHI & R.A. WEISS. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3: 282-286.
113. 113. LE TESSIER, P., J. P. STOYE, Y. YASUHIRO, C. PATIENCE & R. A. WEISS. 1997. Two sets of human-tropic pig retrovirus. Nature 389: 681-682.
114. 114. WILSON, C.A., S. WONG, J. MULLER, C.E. DAVIDSON, T.M. ROSE & P. BURD. 1998. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol. 72: 3082-3087.
115. 115. AKIYOSI, D.E., M. DENARO, H. ZHU, J.L. GREENSTEIN, P. BANERJEE & J.A. FISHMAN. 1998. Identification of a full length cDNA for an endogenous retrovirus of miniature swine. J. Virol. 72: 4503-4507.
116. 116. COFFIN, J.M. 1990. Retroviridae and their replication. In Fields Virology, 2nd edition. B.N. Fields, D.M. Knipe, R.M. Chanock, et al., Eds.: 1437-1500. Raven Press. New York.
117. 117. PATIENCE, C., G.S. PATTON, Y. TAKEUCHI, R.A. WEISS, M.O. McCLURE, L. RYDBERG & M.E. BREIMER. 1998. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 352: 699-701.